DUXAP10 and esophageal squamous cell carcinoma: DUXAP10 has been found to be expressed at high levels in ESCC tissues and cells (KYSE30, KYSE510, KYSE180, and KYSE150 cells), whereas overexpression of DUXAP10 was closely correlated with short survival time, TNM stage, and lymph node metastasis.